Mayur M Amonkar (Mayur Amonkar)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Locally Advanced

Health Insurance

Drug Administration

Top Venues

Future oncology (London, England)

Journal of gastrointestinal cancer

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Lauren A Abderhalden, Ping Wu, Mayur M Amonkar, Brian Matthew Lang, Sukrut Shah, Fan Jin, Andrew M Frederickson, Ali Mojebi
Clinical Outcomes for Previously Treated Patients with Advanced Gastric or Gastroesophageal Junction Cancer: A Systematic Literature Review and Meta-Analysis. Journal of gastrointestinal cancer (2023)
Raquel Aguiar-Ibáñez, Chloë Hardern, Frank van Hees, Dawn Lee, Anubhav Patel, Nitika Chhabra, Gargi Baluni, Mayur M Amonkar, Yizhen Lai, Ruifeng Xu, Rachid Massaad, David Fogelman
Cost-effectiveness of pembrolizumab for the first-line treatment of patients with unresectable or metastatic MSI-H/dMMR colorectal cancer in the United States. Journal of medical economics 25 (1) (2022)
He Jin, Mayur M Amonkar, Raquel Aguiar-Ibáñez, Manasi Thosar, Monica Chase, Sam Keeping
Systematic literature review and network meta-analysis of pembrolizumab versus other interventions for previously untreated, unresectable or metastatic, MSI-high or MMR-deficient CRC. Future oncology (London, England) 18 (17) (2022)